98 related articles for article (PubMed ID: 7545888)
1. Advantage--FK 506: reduced chronic rejection for lung transplant recipients.
Bolman RM
Ann Thorac Surg; 1995 Sep; 60(3):495-6. PubMed ID: 7545888
[No Abstract] [Full Text] [Related]
2. Clinical trial of tacrolimus versus cyclosporine in lung transplantation.
Keenan RJ; Konishi H; Kawai A; Paradis IL; Nunley DR; Iacono AT; Hardesty RL; Weyant RJ; Griffith BP
Ann Thorac Surg; 1995 Sep; 60(3):580-4; discussion 584-5. PubMed ID: 7545889
[TBL] [Abstract][Full Text] [Related]
3. A randomized controlled trial of tacrolimus versus cyclosporine after lung transplantation.
Hachem RR; Yusen RD; Chakinala MM; Meyers BF; Lynch JP; Aloush AA; Patterson GA; Trulock EP
J Heart Lung Transplant; 2007 Oct; 26(10):1012-8. PubMed ID: 17919621
[TBL] [Abstract][Full Text] [Related]
4. International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection.
Sarahrudi K; Estenne M; Corris P; Niedermayer J; Knoop C; Glanville A; Chaparro C; Verleden G; Gerbase MW; Venuta F; Böttcher H; Aubert JD; Levvey B; Reichenspurner H; Auterith A; Klepetko W
J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1126-32. PubMed ID: 15052212
[TBL] [Abstract][Full Text] [Related]
5. Tacrolimus versus cyclosporine for adult lung transplant recipients: a meta-analysis.
Fan Y; Xiao YB; Weng YG
Transplant Proc; 2009 Jun; 41(5):1821-4. PubMed ID: 19545736
[TBL] [Abstract][Full Text] [Related]
6. The value of switching from cyclosporine to tacrolimus in the treatment of refractory acute rejection and obliterative bronchiolitis after lung transplantation.
Sarahrudi K; Carretta A; Wisser W; Senbaklavaci O; Ploner M; Neuhauser P; Dobrovits M; Miwai Marta G; Papp A; Klepetko W
Transpl Int; 2002 Jan; 15(1):24-8. PubMed ID: 11875609
[TBL] [Abstract][Full Text] [Related]
7. Overview of tacrolimus-based immunosuppression after heart or lung transplantation.
Reichenspurner H
J Heart Lung Transplant; 2005 Feb; 24(2):119-30. PubMed ID: 15701425
[TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation of trough levels and area under the curve in cyclosporine- and FK 506-treated kidney transplant recipients.
Takahara S; Kokado Y; Kameoka H; Takano Y; Moutabarrik A; Jiang H; Ishibashi M; Okuyama A; Nishi Y; Chiba N
Transplant Proc; 1994 Oct; 26(5):2802-6. PubMed ID: 7524219
[No Abstract] [Full Text] [Related]
9. Cyclosporine C2 target levels and acute cellular rejection after lung transplantation.
Glanville AR; Aboyoun CL; Morton JM; Plit M; Malouf MA
J Heart Lung Transplant; 2006 Aug; 25(8):928-34. PubMed ID: 16890113
[TBL] [Abstract][Full Text] [Related]
10. Tacrolimus (FK 506) therapy is associated with a significant reduction in immunosuppressive treatment failures following primary liver transplantation.
Bechstein WO; Neuhaus P; McMaster P; Calne R; Pichlmayr R; Otto G; Williams R; Ericzon BG; Bismuth H
Transplant Proc; 1996 Apr; 28(2):1008-10. PubMed ID: 8623211
[No Abstract] [Full Text] [Related]
11. Tacrolimus as rescue therapy for bronchiolitis obliterans syndrome.
Kesten S; Chaparro C; Scavuzzo M; Gutierrez C
J Heart Lung Transplant; 1997 Sep; 16(9):905-12. PubMed ID: 9322139
[TBL] [Abstract][Full Text] [Related]
12. FK 506 'rescue' immunosuppression for obliterative bronchiolitis after lung transplantation.
Ross DJ; Lewis MI; Kramer M; Vo A; Kass RM
Chest; 1997 Nov; 112(5):1175-9. PubMed ID: 9367453
[TBL] [Abstract][Full Text] [Related]
13. Dose adjustment and cost of itraconazole prophylaxis in lung transplant recipients receiving cyclosporine and tacrolimus (FK 506).
Kramer MR; Merin G; Rudis E; Bar I; Nesher T; Bublil M; Milgalter E
Transplant Proc; 1997 Sep; 29(6):2657-9. PubMed ID: 9290780
[No Abstract] [Full Text] [Related]
14. FK 506 for rescue treatment of acute and chronic rejection in liver allograft recipients.
Shaw BW; Markin R; Stratta R; Langnas A; Donovan J; Sorrell M
Transplant Proc; 1991 Dec; 23(6):2994-5. PubMed ID: 1721338
[No Abstract] [Full Text] [Related]
15. Tacrolimus therapy for persistent or recurrent acute rejection after lung transplantation.
Horning NR; Lynch JP; Sundaresan SR; Patterson GA; Trulock EP
J Heart Lung Transplant; 1998 Aug; 17(8):761-7. PubMed ID: 9730424
[TBL] [Abstract][Full Text] [Related]
16. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
Rinaldi M; Pellegrini C; Martinelli L; Goggi C; Gavazzi A; Campana C; Arbustini E; Grossi P; Regazzi M; Ippoliti G; Vigano M
J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242
[TBL] [Abstract][Full Text] [Related]
17. The impact of induction on survival after lung transplantation: an analysis of the International Society for Heart and Lung Transplantation Registry.
Hachem RR; Edwards LB; Yusen RD; Chakinala MM; Alexander Patterson G; Trulock EP
Clin Transplant; 2008; 22(5):603-8. PubMed ID: 18435784
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[TBL] [Abstract][Full Text] [Related]
19. Neurotoxicity of FK 506 in liver transplant recipients.
Frank B; Perdrizet GA; White HM; Marsh JW; Lemann W; Woodle ES
Transplant Proc; 1993 Apr; 25(2):1887-8. PubMed ID: 7682355
[No Abstract] [Full Text] [Related]
20. A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients.
Shenoy S; Hardinger KL; Crippin J; Korenblat K; Lisker-Melman M; Lowell JA; Chapman W
Liver Transpl; 2008 Feb; 14(2):173-80. PubMed ID: 18236391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
